Transmission of sheep-bovine spongiform encephalopathy to pigs by unknown
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Abstract 
Experimental transmission of the bovine spongiform encephalopathy (BSE) agent has been successfully reported in 
pigs inoculated via three simultaneous distinct routes (intracerebral, intraperitoneal and intravenous). Sheep derived 
BSE (Sh-BSE) is transmitted more efficiently than the original cattle-BSE isolate in a transgenic mouse model express-
ing porcine prion protein. However, the neuropathology and distribution of Sh-BSE in pigs as natural hosts, and 
susceptibility to this agent, is unknown. In the present study, seven pigs were intracerebrally inoculated with Sh-BSE 
prions. One pig was euthanized for analysis in the preclinical disease stage. The remaining six pigs developed neuro-
logical signs and histopathology revealed severe spongiform changes accompanied by astrogliosis and microgliosis 
throughout the central nervous system. Intracellular and neuropil-associated pathological prion protein (PrPSc) depo-
sition was consistently observed in different brain sections and corroborated by Western blot. PrPSc was detected by 
immunohistochemistry and enzyme immunoassay in the following tissues in at least one animal: lymphoid tissues, 
peripheral nerves, gastrointestinal tract, skeletal muscle, adrenal gland and pancreas. PrPSc deposition was revealed by 
immunohistochemistry alone in the retina, optic nerve and kidney. These results demonstrate the efficient transmis-
sion of Sh-BSE in pigs and show for the first time that in this species propagation of bovine PrPSc in a wide range of 
peripheral tissues is possible. These results provide important insight into the distribution and detection of prions in 
non-ruminant animals.
© 2016 Hedman et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
Transmissible spongiform encephalopathies (TSE) are 
chronic neurodegenerative disorders that affect humans 
and animals and are associated with the accumulation of 
an abnormal isoform (PrPSc) of the cellular prion protein 
(PrPC) in the central nervous system (CNS) [1]. TSE are 
characterized by spongiform changes in the grey mat-
ter accompanied by astrocytosis and microgliosis [2–4]. 
The new variant of Creutzfeldt-Jakob disease (nvCJD) 
in humans [5] has been linked with the consumption of 
bovine spongiform encephalopathy (BSE) contaminated 
meat or meat products during the BSE epidemic in the 
UK and elsewhere. Moreover, one BSE natural case in a 
goat in France [6] and another one in the UK [7, 8] have 
been reported. Sheep and goats can also be experimen-
tally infected using homogenized brain from affected 
animals as inocula [9–11]. While BSE infection is largely 
restricted to the nervous system in cattle [12, 13], PrPSc 
is widely distributed in the lymphoid tissues of sheep 
experimentally infected with BSE [10, 14], suggesting that 
infected sheep could constitute a secondary and more 
dangerous source of BSE infection for other species, 
including humans [15–17].
TSE has not been reported in natural conditions in 
pigs [18], and there is no evidence of BSE transmission 
between pigs fed with brain material from cattle [19]. 
However, despite the existence of a strong transmission 
barrier, signs of TSE have been reported in pigs chal-
lenged simultaneously with BSE-derived material via 
intraperitoneal, intravenous and intracerebral adminis-
tration [20–22]. Those studies demonstrated pathological 
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changes and PrPSc deposition in the CNS, but reported 
no evidence of PrPSc distribution in other organs. Given 
the possible lifting of the European Union’s ban on feed-
ing pigs and poultry with animal meal, it is vital that TSE 
transmission be studied in supposedly resistant species, 
such as swine, that form part of the human food chain. 
Pigs are the source of a wide range of food products, and 
pork is one of the most widely eaten meats in the world. 
Blood is frequently collected during slaughter for blood 
sausage production and natural sausage casings are 
almost exclusively prepared from different parts of the 
alimentary tract of pigs. The use of pigs as graft donors 
is also a cause for concern, given a reported case of CJD 
type 1 in a recipient of a porcine dura-mater graft [23]. 
It has also been demonstrated that BSE experimen-
tally passaged in sheep (Sh-BSE) homozygous for the 
A136R154Q171 allele of ovine prion protein (PrP) exhibits 
altered pathobiological properties due to a decreased 
polymorphism barrier [24]. The virulence of Sh-BSE in 
transgenic mice expressing porcine [15] and human PrP 
[16, 25] is enhanced with respect to the original cattle 
BSE prion isolate.
This study is the first to describe the tissue distribution 
of PrPSc in pigs experimentally infected with BSE previ-




All procedures were carried out under Project License 
COTSA EFA 85/08 and CONCOTSA EFA 205/11 and 
were approved by the in-house Ethic Committee for Ani-
mal Experiments under license PI 13/10 from the Univer-
sity of Zaragoza. All animal experiments were performed 
in accordance with the Spanish Policy for Animal Protec-
tion RD1201/05 and European Union Directive 86/609 
for the protection of animals used for experimental and 
other scientific purposes.
Sheep BSE inoculum
Sheep BSE isolate (Sh-BSE) was originally derived from 
a pool of ARQ/ARQ sheep that were experimentally 
infected by intracerebral inoculation with the BSE agent 
[26]. This isolate was supplied by the Institut National de 
la Recherche Agronomique (INRA-Toulouse, France).
Experimental challenge of pigs with sheep BSE
Eight 8-month old minipigs (1 castrated male and 7 
females) from the Instituto Madrileño de Investigación 
y Desarrollo Rural, Agrario y Alimentario (IMIDRA), 
were intracerebrally inoculated under general anesthesia. 
Seven animals were challenged with 0.5 mL of inoculum 
consisting of a 10% homogenate of the Sh-BSE agent in 
sterile saline solution, administered in a single injection. 
One animal was challenged with 0.5 mL of sterile saline 
solution. The injection site was located 1  cm lateral to 
the midline in the frontal region. The trephine was per-
formed with a dental drill and the inoculate administered 
via a 20G × 2 ¾” needle.
Clinical monitoring
Pigs were monitored daily by animal husbandry staff, and 
1–7 veterinary clinical assessments were carried out per 
week, depending on the stage of the animals.
Tissue sample collection
Animals were euthanized by exsanguination after intra-
venous pentobarbital injection (DOLETHALND®; 
10  mg/kg), which was administered on observation of 
clinical signs suggesting an encephalopathy or the pres-
ence of a life-threatening or welfare-compromising dis-
ease. Necropsies were conducted systematically and 
samples collected from the central nervous system 
(CNS), peripheral nervous system (PNS), lymphoreticu-
lar system (LRS), gastrointestinal tract (GIT), skeletal 
muscles and other tissues. In all cases, tissues samples 
were collected in duplicate; one sample was stored at 
−80 °C and the other in 10% formal saline solution.
Histopathology and immunohistochemistry
For detailed CNS studies, transverse sections of the fol-
lowing areas were selected and stained with hematoxylin 
and eosin (H&E): frontal cortex (FC), basal ganglia (BG), 
lateral frontal cortex (LFC), thalamus (T), hypothala-
mus (Ht), temporal/parietal cortex (TPC), hippocampus 
(HC), occipital cortex (OC), mesencephalon (Ms), cer-
ebellum (Cbl), 4 neuronal nuclei [the hypoglossal motor 
nucleus (HMN); the nucleus of the trigeminal nerve spi-
nal tract (NTN); the olivary nucleus (ON); and the dorsal 
motor nucleus of the vagus nerve (DMNV)], the reticu-
lar formation (RF) of the medulla oblongata (MO), and 
the cervical (CSC), thoracic (TSC), and lumbar spinal 
cord (LSC). PrPSc detection was performed in adjacent 
sections following pretreatment with 98% formic acid, 
hydrated and autoclaved to enhance antigen retrieval. 
After proteinase K digestion (4 g/mL), the sections were 
incubated with blocking reagent (DAKO) for 10  min 
to block endogenous peroxidase activity, as previously 
described [27]. Next, sections were incubated with the 
monoclonal primary antibody 2G11 (1:400) [28] at room 
temperature (RT) for 1  h. The study of the PrPSc depo-
sition types and distribution pattern were based on the 
descriptions reported in natural and experimental scra-
pie, and experimental BSE in sheep [29–31].
Astrocytosis was evaluated using glial fibrillary acidic 
protein (GFAP) immunostaining, as previously described 
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[32], and microglia identified in FC, BG, T, Hc, Cbl, MO 
and CSC sections by immunohistochemical detection of 
the active form of a calcium-binding protein, specially 
expressed in microglia cells (Iba-1). After heat-induced 
epitope retrieval by pretreatment with citrate buffer 
(pH 6.0), sections were incubated for 1 h at RT with the 
primary anti-GFAP antibody (rabbit polyclonal, 1:500; 
DAKO) and overnight at 4 °C with Iba-1 (goat polyclonal 
1:600; Abcam), respectively. Sections were subsequently 
counterstained with hematoxylin.
Western blotting
Samples were treated with proteinase K, subjected to 
sodium dodecyl sulfate polyacrylamide gel electropho-
resis (SDS-PAGE), and blotted onto membranes accord-
ing to the Prionics AG (Schlieren, Switzerland) Check® 
Western BSE test protocol [33], using Sha31 monoclonal 
antibody (1:8000; Spibio A03212), the Bio-Rad VersaDoc 
imaging system and Quantity One 1-D Analysis Software 
(Bio-Rad) for visualization.
IDEXX HerdChek® BSE‑Scrapie Antigen Test
A ligand-based enzyme immunoassay (IDEXX Herd-
Chek® BSE-Scrapie Antigen Test, hereafter referred to 
as IDEXX), which does not use a PK digestion step, was 
used to analyze a wide number of samples according to 
the manufacturer’s instructions, using the conjugate for 
cattle in each sample. Samples (300 mg) were processed 
as previously described for sheep tissues [34]. The nega-
tive cut-off value applied for the bovine conjugate was 
0.14 absorbance units.
Data analysis
Vacuolation, PrPSc deposition, astrocytosis and micro-
gliosis in the CNS were evaluated in the stained sections 
and scored on a scale ranging from 0 to 5 (0 = not detect-
able; 1 = occasional; 2 = mild; 3 = moderate; 4 = severe; 
5  =  extreme). A possible correlation between lesions 
and immunolabeling in the CNS was evaluated using 
the non-parametric Spearman’s rho measure. P  <  0.05 
was considered significant, P < 0.01 very significant and 
P < 0.001 highly significant. Lesion and immunolabeling 
scores were plotted as a function of the anatomical area, 
and data expressed as the mean ± standard deviation.
In peripheral tissues, positive results were scored 
according to the intensity of PrPSc labeling, and were 
classified as negative (−), minimal-to-mild (+), moderate 
(++) or strong (+++).
Results
Details of incubation period, date of euthanasia, clinical 
signs and PrPSc detection by IHC and WB in the brains of 
all animals are provided in Table 1.
Clinical signs and disease course
One pig (P-7) was euthanized for preclinical analysis at 
42 weeks post-injection (wpi). The remaining inoculated 
animals developed clinical signs between 77 and 109 wpi 
[100 ± 12.9 wpi, mean and standard error of the mean 
(SEM)]. Behavioral changes were the first clinical signs 
observed. Animals became highly apprehensive and 
over-reactive, squealing loudly and fleeing in apparent 
panic whenever approached or touched. Subsequent 
behavioral changes suggested confusion in all pigs and 
depression in 5, which showed listlessness. P-6 showed 
apparent confusion and anxiety that increased with the 
progression of the disease. Behavioral changes were 
accompanied by initially mild hind-limb ataxia followed 
by progressive locomotor disability with generalized 
ataxia of gait, weakness and other movement disorders 
in all pigs. Pigs showed low carriage of the head and ears 
and signs of tremor in the shoulder regions, flanks and 
the ears. Persistent recumbency with difficulty rising was 
also observed.
Table 1 Clinical and pathological features.
Animal identification number, incubation period, euthanasia date, clinical signs, neuropathological changes (NPC) as determined by hematoxylin-eosin (HE) staining, 
presence of PrPSc  (immunohistochemistry) and presence of PrPres in CNS samples (Western blot).




Clinical Signs NPC PrPSc PrPres
P-1 96 116 Present-Dull form Present Present Present
P-2 109 132 Present-Dull form Present Present Present
P-3 96 115 Present-Dull form Present Present Present
P-4 109 131 Present-Dull form Present Present Present
P-5 77 90 Present-Dull form Present Present Present
P-6 109 131 Present-Aggressiveness Present Present Present
P-7 42 Absent Absent Absent Absent
P-8 Absent Absent Absent
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Histopathology and immunohistochemistry of the CNS
Microscopic evaluation revealed occasional neuropil vac-
uolation in the molecular layer of the cerebral and cer-
ebellar cortex, thalamus/hypothalamus (Figure  1A) and 
white matter of different brain sections of the control and 
preclinical disease stage pigs. Unlike in other species, the 
incidental vacuolation in the pig cannot be unequivocally 
differentiated from TSE specific vacuoles, a lesion pro-
file from the negative control is also presented for com-
parison. Large intraneuronal and neuropil vacuolation 
(spongiform changes) and increased glial cell reaction 
were observed only in the CNS of pigs that developed 
neurological signs.
Five of the 6 clinically affected pigs showed severe neu-
ropil and neuronal vacuolation in the cerebral cortex. 
This effect was milder in P-2. Lesions were more severe 
in frontal versus occipital areas and were severe in deeper 
layers of the cerebral cortex. In the basal ganglia, severe 
neuropil vacuolation was observed in the caudate nucleus 
in all clinical animals. Neuronal vacuolation in the sep-
tum was moderate in 5 pigs and mild in one case (P-1). In 
hippocampal regions CA1 and CA3 neuronal vacuolation 
was severe in P-1 and P-3, and mild in the remaining 4 
pigs. Occasional neuropil vacuolation of the gyrus denta-
tus was observed in P-1 and P-3.
Lesions decreased in intensity in a rostro-caudal direc-
tion in the brain stem. All pigs showed extreme vacu-
olation in the thalamus (Figure  1B) and relatively mild 
vacuolation in the hypothalamus. Moderate-to-severe 
neuropil vacuolation and a mild-to-moderate neuronal 
Figure 1 Histopathological and immunohistochemical features (A, B, D, E, G, H) and corresponding scoring (C, F, I) in brain sections 
from experimental pigs. A H&E staining, single neuropil vacuole in thalamus of control pig, B neuropil and intraneuronal vacuolation in Sh-BSE 
pig, and C comparative scoring. GFAP staining: D cerebellar cortex of control pig, E increased astrocytic reaction in clinically affected pig, and F 
comparative scoring. Iba-1 staining: G hippocampus of control pig, H increased number of reactive microglia in clinical pig, and I comparative scor-
ing. Scores represent the mean ± standard error. Areas: FC frontal cortex, BG basal ganglia, LFC lateral frontal cortex, T thalamus, Ht hypothalamus, 
TPC temporal/parietal cortex, HC hippocampus, OC occipital cortex, Cbl cerebellum, MO medulla oblongata, CSC cervical, TSC thoracic, LSC lumbar 
spinal cord.
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vacuolation were observed in the mesencephalon of P-2, 
P-4 and P-6, particularly in the red nuclei, trigeminal 
and facial medullary nuclei. Occasional mild spongiosis 
was detected in the oculomotor nuclei. In the medulla 
oblongata, mild-to-moderate spongiosis was observed 
in the HMN, RF and ON and moderate-to-severe spon-
giosis in the DMNV and NTN. Occasional neuronal 
vacuoles were observed in the HMN, NTN, ON and RF 
and mild vacuolation in the DMNV. In all pigs the dorsal 
and ventral horns of the spinal cord exhibited occasional 
neuronal and neuropil vacuolation. All lobes of the cer-
ebellar cortex showed severe vacuolation, especially the 
molecular and granule-cell layers. Histopathological dif-
ferences between control and affected animals are shown 
in Figure 1C.
GFAP immunostaining in the control pig (P-8) 
revealed non-reactive astrocytes, mainly in white mat-
ter, mild staining of fine fibers in the grey matter, and 
moderate ependymal and perivascular staining in all 
sections. In the HC, GFAP staining was observed in the 
molecular layer adjacent to the granular cell layer in the 
fascia dentata. Occasional-to-mild staining in the gran-
ular and molecular layers was also seen in the control 
cerebellum (Figure  1D). P-8 showed a mild increase in 
GFAP staining. A widespread and marked increase in 
GFAP expression was observed in the brains of clini-
cally-affected pigs. This increase was due to the greater 
abundance of large size astrocytes in the gray and 
white matter, mainly in the FC, BG, T and Cbl. Immu-
nolabelling was also observed in the prolongations of 
Bergmann glia of the molecular layer of the cerebel-
lum (Figure 1E). Differences in the distribution of GFAP 
staining between control and Sh-BSE brain sections are 
shown in Figure 1F.
Microglia was analyzed by specific Iba-1 IHC, which 
revealed immunolabelling in the white matter in various 
sections of the negative control pig (Figure 1G). An abun-
dance of microglia with much larger round or amoeboid 
cell bodies was observed in the brain sections of clinically 
affected pigs (Figure  1H). The increase in Iba-1 expres-
sion was particularly marked in the T, HC and Cbl, and 
less immunolabeling in the spinal cord (Figure 1I).
IHC revealed no PrPSc deposition in the CNS of the 
control and preclinical animals. Nine different deposi-
tion types were clearly identified in the CNS of the clini-
cally affected pigs and confirmed the diagnosis of a TSE 
in these animals. The PrPSc types found were as follows:
Intraneuronal type (ITNR): accumulation of fine to 
coarse granular deposits of PrPSc in the neuronal peri-
karya surrounding the nucleus (Figure 2A). This pattern 
was especially observed in different sections of the spinal 
cord, DMNV, NTN and ON nuclei in medulla oblongata, 
thalamus and hippocampus.
Intra-astrocytic type (ITAS): this type was expressed 
by multiple small granules scattered in the cytoplasm of 
astrocyte-resembling cells.
Intra-microglial type (ITMG): characterized by one as 
single or a few large granules in close proximity to micro-
glia-like nuclei.
Both ITAS and ITMG were found in all the sections, 
especially in thalamus and hippocampus, but well identi-
fied in the white matter of cerebral (Figure 2B) and cer-
ebellar cortex, although in less amounts than in the grey 
matter.
Perineuronal type (PNER): thin deposits of PrPSc 
around the plasmalemma of the neuronal bodies 
observed in moderated levels in different basal ganglia 
nuclei (Figure 2C).
Linear type (LINR): thick thread-like deposits of PrPSc 
in the neuropil occasionally present in the basal ganglia 
(Figure 2C) and hippocampus associated to PRCO type.
Perivascular type (PRVS): thick, strongly labeled PrPSc 
accumulation around blood vessels located in the gray 
matter of the cerebral cortices (Figure 2D).
Perivaculoar type (PRVC): PrPSc deposits surrounding 
vacuolar lesions were detected in cerebral (Figure  2D) 
and cerebellar cortex, basal ganglia and thalamus in all 
the pigs.
Subpial type (SBPL): continuous loose mesh of PrPSc 
accumulation underneath the pia mater, especially in the 
cerebral (Figure 2E) and cerebellar cortex.
Particulate to coalescing type (PRCO): Conspicu-
ous deposits in the neuropil associated with amorphous 
masses of PrPSc were observed in the gray matter of the 
cerebral cortex (Figure  2F), it was diffuse in 5 pigs and 
multifocal in P-4. This pattern was also observed in the 
cerebellar cortex, basal ganglia, thalamus/hypothalamus 
and hippocampus. Fine particles were observed in the 
septal and caudate nuclei in basal ganglia.
The predominant PrPSc types present in the CNS of all 
the pigs were the ITNR and the PRCO, while the LINR 
type was the less observed (Figure 2G).
The PrPSc distribution pattern along the different sec-
tions of the CNS revealed that the higher deposits were 
observed in the cerebral cortex; thalamus and cerebel-
lum, whilst the lowest depositions were in the hypothala-
mus and spinal cord (Figure 2H).
The global Spearman correlation values for histopa-
thology and immunohistochemistry in all samples are 
shown in Table 2. Spongiform changes were significantly 
correlated (P < 0.001) with PrPSc deposition. Despite no 
correlation between spongiform changes and glial reac-
tivity, PrPSc deposition was significantly correlated with 
GFAP and Iba-1 immunostaining. Moreover, a signifi-
cant correlation was observed between GFAP and Iba-1 
immunostaining (P < 0.001).
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Histopathology and PrPSc detection in the retina
The control pig showed no histopathological changes in 
the optic nerve or retina (Figure 3A). However, clinically 
affected pigs showed histological lesions of the retina of 
varying degrees of severity. Histopathological findings 
included loss of outer limiting layer definition, outer 
plexiform layer (OPL) atrophy, and disorganization and 
loss of nuclei of both outer (ONL) and inner nuclear lay-
ers (INL). A thickening of the photoreceptor layer (PS) 
was also observed, a result of the disorganization and 
elongation of the photoreceptor segments (Figure  3B). 
While no PrPSc was detected in the optic nerve or retina 
(Figure 3C) of the control pig, occasional granular PrPSc 
deposition was observed in the optic nerve of five clini-
cally affected pigs. PrPSc was also observed in the neu-
roretina of all clinically affected pigs in the ganglion cell 
layer, OPL and IPL. The deposition pattern was granular 
in the plexiform layers of the retina and intraneuronal in 
the ganglion cell layer (Figure 3D). PrPSc was not detected 
in any ocular tissues other than the neuroretina.
Figure 2 PrPSc types and distribution pattern in different sections of the CNS of clinically affected pigs. A Intraneuronal (ITNR) type, B 
intra-astrocytic (ITAS) and intra-microglial (ITMG) type, C perineuronal (PNER) and linear (LINR) type, D perivascular (PVAS) and perivacuolar (PVAC) 
types, E subpial (SBPL) type, F particulate/coalescing (PRCO) showing amorphous aggregations (arrowheads). G Scoring PrPSc profile of the deposi-
tion types. H PrPSc distribution in CNS. Scores represent the mean ± standard error. Areas: FC frontal cortex, BG basal ganglia, LFC lateral frontal 
cortex, T thalamus, Ht hypothalamus, TPC temporal/parietal cortex, HC hippocampus, OC occipital cortex, Cbl cerebellum, MO medulla oblongata, 
CSC cervical, TSC thoracic, LSC lumbar spinal cord.
Table 2 Spearman correlation values between histologi-
cal features (vacuolation and PrPSc; GFAP and Iba-1) in all 
groups.
Correlations were estimated using the full set of data obtained from all CNS 
sections (global correlation)
Empty cells No correlation or duplicated results
** Correlation is very significant at the 0.01 level
*** Correlation is highly significant at the 0.001 level
Spearman’s rho PrPSc GFAP Iba‑1
Vacuolation 856 (***)
PrPSc 331 (**) 316 (**)
GFAP 912 (***)
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Western blot analysis
Western blot revealed no PrPres in the CNS of pre-
clinical (P-7) and control (P-8) pigs. However, brain 
sections from clinically affected pigs showed a character-
istic 3-band pattern. The medulla oblongata band signal 
appeared to be less intense than the frontal cortex, thala-
mus and cerebellum samples (Figure 4A). Differences in 
the molecular signature between the original inoculum 
(Sh-BSE) and sheep-BSE in pigs were observed. The 
molecular mass of the diglycosylated band of Sh-BSE 
was higher than that of porcine Sh-BSE, which produced 
a predominant monoglycosylated band. By contrast, the 
molecular masses of the unglycosylated PrPres were simi-
lar (Figure 4B).
Immunoassay analysis
The results of IDEXX revealed optical density (OD) val-
ues of 0.03 in the negative control and 3.695–4.349 in the 
CNS of clinically affected pigs (Table 3).
Histopathology, immunohistochemistry and immunoassay 
of the peripheral tissues
No histopathological changes were observed outside the 
CNS of clinically affected pigs. However, IHC and/or 
IDEXX revealed widespread PrPSc distribution in organs 
outside the CNS of these animals. Individual results of 
the PrPSc detection assay are provided in Table 3.
PrPSc detection in the peripheral nervous system (PNS)
The vagus nerve resulted positive by the PrPSc detected 
in the DMNV in the MO by IHC. Both IHC and IDEXX 
revealed PrPSc in the brachial nerve of P-2 and P-3 with 
OD values ranging from 0.173 to 0.208 and in the sciatic 
nerve in all pigs, with OD values ranging from 0.160 to 
0.430. Transversal sections of peripheral nerves showed 
small amounts of periaxonal labeling in some nerve fibers 
(Figure 5A). No neural PrPSc was detected in the control 
pig (Figure 5B).
Figure 3 Photomicrographs of retinal cross-sections from negative control (A, C) and clinically affected pigs (B, D). All layers of the con-
trol retina (A) show normal organization and cytoarchitecture. GCL ganglion cell layer, IPL inner plexiform layer, INL inner nuclear layer, OPL outer 
plexiform layer, ONL outer nuclear layer, PS photoreceptor segments. B Moderate disorganization and decreased cellular density is observed within 
the INL and ONL in clinically affected pigs. C Absence of PrPSc staining in control retina. D Granular intra- and extraneuronal deposition in GCL, IPL 
and OPL of Sh-BSE pig.
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PrPSc detection in the lymphoreticular system (LRS)
In P1 and P4, PrPSc was detected in the palatine tonsil 
in the form of granules in tingible body macrophages 
(TBM) present in the lymphoid follicles (Figure  5C). 
This pattern was also observed in the submandibular 
lymph node in P-2, the mediastinal lymph node in P-1, 
and the mesenteric lymph node in P-2, P-4 and P-5, with 
OD values ranging from 0.152 to 0.545 (IDEXX). Neither 
IHC nor IDEXX detected PrPSc in the spleen of clini-
cally affected or control pigs. Gut associated lymphoid 
tissues (GALT) were also negative in all cases. No PrPSc 
was observed in the lymphoid tissues of the control pig 
(Figure 5D).
PrPSc detection in the gastrointestinal tract (GIT)
PrPSc deposits were consistently detected in the enteric 
nervous system, with granular intracytoplasmic accumu-
lation observed in neurons of the myenteric (Auerbach’s) 
plexus (Figure  5E). Positivity was detected in the stom-
ach, duodenum, jejunum, ileum, caecum, colon and rec-
tum, with levels varying between animals. P-1, which was 
euthanized at 116 wpi, showed more positive sections 
than P-2, P-4 or P-6, which had longer incubation peri-
ods. Positive staining was also detected in the duodenum 
and jejunum in three and four pigs, respectively, and in 
the caecum, colon and rectum in one of the six pigs. Both 
methods revealed positive staining in the distal ileum in 
all pigs. This finding suggests that the ileum is the first 
part of the GIT to be reached by prions. No PrPSc accu-
mulation was observed in the negative control or preclin-
ical pigs (Figure 5F).
PrPSc detection in skeletal muscle
Both assay methods detected PrPSc in skeletal muscle 
samples from oculomotor muscle in P-1 and P-4. IHC 
revealed granular PrPSc deposit restricted to the mus-
cle spindles (Figure  5G); PrPSc immunolabeling was not 
detected in myofibrils, intramuscular nerve fascicles or in 
most ganglia in the muscle samples analyzed. PrPSc was 
detected in oculomotor muscle and semitendinosus mus-
cle in P-5 by IDEXX only. No PrPSc accumulation was 
detected by either method in muscle samples from con-
trol and preclinical pigs (Figure 5H).
PrPSc detection in the pancreas
PrPSc was detected in the pancreas of five clinically 
affected pigs by IHC only. PrPSc deposition was observed 
in structures of the PNS. In these samples, intracytoplas-
mic and perineuronal immunolabeling was observed in 
the parasympathetic postganglionic neurons in pancre-
atic tissue (Figure 6A). No PrPSc was detected in P-2 or 
in the control pig (Figure  6B). No pancreatic PrPSc was 
detected in any of the pigs analyzed using the IDEXX 
technique.
PrPSc detection in the adrenal gland
PrPSc was detected in the medullar region of the adre-
nal gland of P-2 in the form of granular intracytoplas-
mic deposits in ganglionic neurons and chromaffin cells 
(Figure 6C). IDEXX revealed an OD value of 0.150. How-
ever, IHC revealed no clear positivity for PrPSc in P-5, 
for which IDEXX determined an OD of 0.191. No PrPSc 
was detected in the adrenal gland of any other clinically 
affected or control pigs (Figure 6D).
PrPSc detection in the kidney
Granular PrPSc deposition was observed exclusively 
within the epithelial tubular cells of the convoluted tubes 
and collecting ducts in P-1 (Figure  6E). This result was 
not consistent with the IDEXX result, which was nega-
tive. The kidneys of the remaining clinically affected and 
control pigs were negative in both assays (Figure 6F).
Discussion
This study was aimed at investigating the susceptibility 
and neuropathological features of pigs intracerebrally 
inoculated with the BSE agent after passage in sheep, as 
Figure 4 Sh-BSE glycosylation pattern in pigs. A Minigel: PrPres 
in frontal cortex (FC) thalamus (T) cerebellum (Cbl) and medulla 
oblongata (MO) of 3 clinically affected pigs. B Bio-Rad gel: molecular 
signature of bovine spongiform encephalopathy after passage in 
sheep (Sh-BSE) and of sheep-BSE in pigs. Note the difference in PrPres 
glycosylation in the original sheep BSE versus porcine sheep-BSE. No 
differences were observed in the molecular masses of the ungly-
cosylated forms of PrPres. M, are 20.1 and 29.1 kD molecular mass 
markers.
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well as describing the PrPSc distribution in peripheral tis-
sues in this species.
In the present study, seven pigs were intracerebrally 
inoculated with 0.5  mL of 10% Sh-BSE homogenate. 
Except in one animal (P-7), which was euthanized for 
preclinical analysis, the transmission rate was 100%, with 
an incubation period range of 77–109 wpi. Two previous 
studies in which bovine BSE has been transmitted to pigs, 
reported 87.5% and 20% of rate attacks, with incubation 
period ranges of 74–163 and 148–175 wpi, respectively 
[19, 20]. Sh-BSE infected pigs show slightly shorter incu-
bation periods. However, it is not possible to compare 
the incubation period of our inoculated pigs with respect 
to the incubation period found in the studies mentioned 
above, due to the lack of titration of the original inocu-
lum. Moreover, the incubation period could also be 
modified in TSE due to the species barrier, which is mod-
ulated by specific polymorphisms of the PRNP gene and 
Table 3 PrPSc detection by immunohistochemistry (IHC) and IDEXX in the central nervous system (CNS), peripheral nerv-
ous system (PNS), lympho-reticular (LRS), gastrointestinal tract (GIT), skeletal muscles (SM) and other organs of individ-
ual pigs.
SITE Tissue P1 P2 P3 P4 P5 P6 P8
IHC EIA IHC EIA IHC EIA IHC EIA IHC EIA IHC EIA IHC EIA
CNS Brain + 4.22 + 3.93 + 3.69 + 3.75 + 3.90 + 4.34 – 0.03
Retina + ND + ND + ND + ND + ND + ND – ND
Optic nerve + ND + ND + ND + ND + ND + ND – ND
PNS Vagus nerve + ND + ND + ND + ND + ND + ND – –
Brachial nerve – – + 0.20 + 0.17 – – – – – – – –
Sciatic nerve + 0.43 + 0.30 + 0.28 + 0.29 + 0.34 + 0.16 – –
LRS Tonsil + 0.17 + 0.08 – – + 0.15 – – – – – –
Retropharyngeal ln. – – – – – – – – – – – – – –
Submandibular ln. – – – 0.35 – – – – – – – – – –
Prescapular ln. – – – – – – – – – – – – – –
Mediastinal ln. + 0.16 – – – – – – – – – – – –
Spleen – – – – – – – – – – – – – –
Mesenterial ln. – – + 0.23 – – + 0.19 + 0.54 – – – –
Popliteal ln. – – – – – – – – – – – – – –
GIT Oesophagus – – – – – – – – – – – – – –
Stomach + – – – – – – – – – + – – –
Duodenum ++ – – – – – ++ – – – + – – –
Jejunum ++ 0.24 – – + – ++ – – – + – – –
Ileum +++ 0.40 +++ 0.72 ++ 0.22 +++ 1.48 + 0.23 ++ 0.31 – –
Caecum + – – – – – – – – – – – – –
Colon + – – – – – – – – – – – – –
Rectum + – – – – – – – – – – – – –
SM Oculomotor + 1.00 – – – – + 2.83 – 0.67 – – – –
Brachial biceps – – – – – – – – – – – – – –
Semitendinosus – – – – – – – – – 0.20 – – – –
Other Tongue – – – – – – – – – – – – – –
Olfactory mucosa – – – – – – – – – – – – – –
Heart – – – – – – – – – – – – – –
Lung – – – – – – – – – – – – – –
Liver – – – – – – – – – – – – – –
Adrenal gland – – – – + 0.15 – – + 0.19 – – – –
Urinary bladder – – – – – – – – – – – – – –
Kidney + – – – – – – – – – – – – –
Pancreas + – – – + – + 0.21 + – + – – –
Uterus – – – – – – – – – – – – – –
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Figure 5 Immunohistochemical detection of PrPSc in peripheral tissues. A Brachial nerve fiber bundle showing periaxonal PrPSc immuno-
labeling (arrowheads). C Tonsil showing PrPSc immunolabeling within tingible body macrophages (TBMs). E Intraneuronal PrPSc deposition in ileal 
myenteric plexus (arrow heads) in pig P-2. G Granular deposition in neuromuscular spindle (circle) of the oculomotor muscle of pig P-4. B, D, F, H 
Corresponding negative control tissues.
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plays a key role in susceptibility to prion disease in other 
species such as sheep [35, 36], and goats [37]. Although 
some studies show that there are no differences in the 
sequence of the porcine PRNP gene [38–40], the possibil-
ity of changes in other regions of the gene or the involve-
ment of other genes in the incubation periods of BSE in 
pigs should not be excluded. In addition, the restricted 
number of animals used does not allow comparing 
difference on rate attacks in previous studies with the 
present report. However, transmissible studies in por-
cine PRNP transgenic mice (Tgpo) has demonstrated that 
the Sh-BSE agent reached rate attack of 100% and lower 
survival time when compared to the original bovine BSE 
(19%) and other BSE isolates at first passage [15]. At two 
subsequent passages, the transmission rate of both Sh-
BSE and bovine BSE was reported to be similar (100%) 
Figure 6 Immunohistochemical detection of PrPSc in peripheral tissues. A Intrapancreatic ganglia neurons showing perineuronal (*) and 
granular intracytoplasmic labeling (arrow). C Adrenal gland showing granular deposits in ganglionic neurons (red circle) and chromaffin cells 
(arrow). E Sh-BSE kidney showing PrPSc deposits in tubular structure (arrow head). B, D, E Absence of a detectable positive signal in corresponding 
tissues from the control pig.
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but always with a lower survival time of the Sh-BSE 
infected mice [15]. Recent studies have demonstrated an 
increase in the PrP-converting potency of Sh-BSE caused 
by decreases in polymorphism barriers [24] and other 
specific cellular factors [25], allowing Sh-BSE to be trans-
mitted more efficiently than cattle BSE to other species 
[16, 17] including supposedly less susceptible hosts such 
as pigs [15]. The current study was in agreement with 
previous reports [20–22] involving intracerebral inocu-
lation of BSE prions to pigs demonstrating that this spe-
cies is susceptible to BSE. However, it is still unknown if 
pigs can succumb to BSE after oral exposure which is the 
most likely route of inoculation under natural conditions.
The clinical signs observed in the present study were 
similar to those described in BSE-infected pigs [20]. 
Animals initially showed progressive confusion, fol-
lowed by motor deficits [19]. The behavioral and sensory 
changes were also consistent with those observed in cat-
tle infected naturally [41] and experimentally with BSE 
[12]. The minimal neuropil vacuoles found in the con-
trol pig are in total agreement with previous studies [21] 
and apparently does not represent a clinical significant 
change [20]. The main pathological changes observed 
were neuropil spongiosis, intraneuronal vacuolation 
and PrPSc deposition, all of which are characteristic of 
TSE [41]. The lesion distribution pattern resembled that 
described previously in experimentally BSE- infected pigs 
[21] and cattle [12]; the thalamus was the most affected 
area, followed by the cerebellar and cerebral corti-
ces, with the mildest effect observed in the spinal cord. 
PrPSc deposits were identified in the CNS of all clinically 
affected pigs. PrPSc deposits were typically associated 
with lesions in the fourth and fifth layers of the cerebral 
cortex. Intracellular (ITNR, ITAS and ITMG) and par-
ticulate/coalescing type PrPSc deposition were the most 
commonly observed patterns in the different CNS sam-
ples, in line with previous findings in sheep [29, 30] and 
pigs [21] experimentally infected with BSE. Similarities 
in the PrPSc deposition types and distribution pattern 
could be explained by the high stability of the BSE agent 
reported for different breeds and different genotypes of 
the prion protein gene (PRNP) in sheep [30]. In addition, 
the porcine PRNP gene has been described to be very 
homogenous [38–40].
The glial reaction in all affected pigs was character-
ized by marked astrocytosis and microgliosis. Astro-
cytosis was diffusely distributed throughout the brain 
of affected pigs, perhaps caused by the accumulation of 
PrPSc or by cytokines secreted from astroglial or micro-
glial cells [42]. Microgliosis was present in the deeper lay-
ers of the gray matter in the cerebral cortex, which also 
showed vacuolation and PrPSc deposition, in accordance 
with previous findings in mice [43]. The most extreme 
microglial activation was observed in the hippocampus 
of all affected pigs, as previously described for CJD [44]. 
Numerous astrocytic processes and reactive microglia 
have been described in pigs experimentally infected with 
BSE [45]. Our results suggest that astrogliosis and micro-
gliosis are common neuropathological features of Sh-BSE 
infection in pigs, as described for TSE in other species 
[28, 43, 45–47].
Histopathological changes indicative of retinal degen-
eration were observed in all clinically affected pigs. This 
has not been previously described in pigs experimentally 
infected with BSE. Neuronal vacuolation in the GCL and 
disorganization in the plexiform and nuclear layers have 
been reported in both experimental [48] and natural 
scrapie infections in sheep [49] and goats [50], chronic 
wasting disease (CWD) in mule deer [51] and in CJD-
infected mice [52]. IHC revealed higher levels of PrPSc in 
the retina than in the optic nerve, where staining was less 
intense and more irregularly distributed, as described 
in both sCJD and nvCJD [53]. The presence of PrPSc in 
the optic nerve and retina is consistent with the cen-
trifugal spread of the agent from the brain, presumably 
via the optic nerve [52]. This may indicate the existence 
of other routes of PrPSc migration to the retina (e.g., via 
the extracellular space [54], the ad-axonal route along the 
optic nerve, or both [55]). Other authors have suggested 
that the spread occurs from the subarachnoid space into 
the perineural space of the optic nerve, and from there 
to the epichoroidal and episcleral tissues of the eyeball 
[56]. Alternatively, the increased presence of PrPSc in the 
retina more than in the optic nerve could be attributed to 
the higher presence of PrPc in the membranes of retinal 
neurons. Our detection of PrPSc in different retinal lay-
ers is in accordance with previous observations in TSE in 
mice [52], feline spongiform encephalopathy (FSE) [57], 
scrapie [49], CWD [51], BSE [56] and in patients with 
sporadic and nvCJD [53].
Western blot revealed a characteristic 3-band pattern 
that clearly differed from the original inoculum, with 
a predominant monoclycosylated band. This finding is 
consistent with previous Western blot findings in BSE-
infected pigs [58]. Our results reinforce the hypothesis 
that this particular signature is associated with the por-
cine PrPc properties described in Tgpo mice [15].
The IDEXX enzyme immunoassay, which is not vali-
dated for PrPsc in pigs, detected PrPSc in samples that 
tested positive in other postmortem assays, but detected 
no PrPsc in negative control tissues. Analysis of periph-
eral tissues revealed widespread dissemination of PrPSc in 
many organs other than the CNS. This finding suggests 
that unlike in cattle where BSE is confined mainly in the 
nervous system, in the pig, BSE prions can propagate in 
peripheral tissues as reported in sheep [59–61]. However, 
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it is not possible to ascertain that the peripheral distri-
bution of the agent is due to centrifugal dissemination 
from the brain through the nerves as it is also probable 
that during an ic challenge part of the inoculum enters 
into the blood circulation and can be disseminated to the 
periphery where it can propagate in target tissues [62].
PrPSc deposition in brachial and sciatic nerves has also 
been described in cattle experimentally infected with 
L-type BSE [63] and in BSE-infected sheep [64].
Immunohistochemistry demonstrated the presence 
of PrPSc in the lymphoreticular system of our Sh-BSE 
infected pigs. The assay revealed sporadic intracytoplas-
mic accumulation within the tingible body macrophages 
in some lymph nodes, findings that were subsequently 
corroborated by IDEXX, in good agreement with pre-
vious findings in sheep experimentally infected with 
BSE [64]. In contrast to our findings, previous stud-
ies reported no infectivity of lymphoid tissues in BSE-
infected pigs [19]. No PrPSc was detected in the spleen or 
GALT of our pigs, in line with previous studies of BSE-
infected cattle [65] and FSE [57].
PrPSc accumulation in the gastrointestinal tract of 
Sh-BSE infected pigs has not been described in similar 
experiments using this species. We observed PrPSc depo-
sition in the myenteric plexi without apparent morpho-
logical alterations of the enteric neurons, as seen in cattle 
experimentally infected with BSE [65]. This finding is 
indicative of a potential centrifugal spread of the Sh-BSE 
agent from the CNS via the vagus nerve to the peripheral 
nervous system, and may account for the large depos-
its of PrPSc observed in the dorsal motor nucleus of the 
vagus nerve in the medulla oblongata.
We observed PrPSc deposition in nerve fibers of the 
oculomotor muscle in two pigs. In cattle naturally 
infected with BSE [66], PrPSc has been detected in intra-
muscular nerve fibers and muscle spindles. Although we 
found no PrPSc in the oculomotor muscle of any other 
clinically affected pigs, positive labeling was observed in 
the oculomotor nuclei in the mesencephalon of all clini-
cally affected pigs.
Pancreatic PrPSc staining was observed in 5 pigs. Anal-
ysis of pancreatic nervous tissue has revealed PrPSc depo-
sition in the islets of Langerhans in natural scrapie [34]. In 
natural BSE [56], PrPSc deposition has been documented 
in the nerve fibers of the adrenal gland. In agreement 
with previous findings in natural scrapie [34], one pig 
showed PrPSc immunolabeling in the medullary region of 
the adrenal gland, associated with chromaffin cells, which 
are considered modified sympathetic postganglionic neu-
rons. Similarly, the presence of PrPSc within the epithelial 
tubular cells of the convoluted tubules and the collecting 
ducts in the kidney in one pig has been described in FSE 
[67], suggesting possible prionuria.
In addition to the large amount of PrPSc observed in 
the CNS of Sh-BSE-infected pigs, PrPSc was widely dis-
tributed in the peripheral tissues, although the extent of 
this distribution varied between animals. This variation 
may be related to the distribution of PrPSc within indi-
vidual organs, the exact anatomical location points at 
which samples were collected, and the detection limits 
of the techniques used. More sensitive studies, such as 
in vitro protein misfolding cyclic amplification (PMCA) 
and mouse bioassays will be needed to clarify the dis-
tribution and infectivity of PrPSc in peripheral tissues 
of Sh-BSE infected pigs. These assays will most likely 
indicate a higher number of PrPSc-positive peripheral 
organs.
Comparison with previous studies of cattle-BSE in 
pigs revealed that the incubation period of Sh-BSE in 
our pigs was generally shorter [20, 21] and that PrPSc 
was present in more peripheral tissue types [19]. We 
believe that these differences may be due to a modi-
fication in the pathogenicity of the cattle-BSE agent 
caused by its prior passage in sheep, as previously 
described in TgPo mice [15]. However, studies of natu-
ral routes of transmission (e.g., oral) will be required 
to determine the real susceptibility of pigs to the Sh-
BSE agent.
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